| Indications | n | % |
| Colposcopy without prior Pap smears |
|
|
| Patients who come on their own for screening | 94 | 21.3 |
| Patientes sent for abnormal VIA-VILI | 251 | 57 |
| Patients directed for: | 48 | 10.9 |
| Contact metrorrhagia | 18 | 4 |
| Post-menopausalmetrorrhagia | 20 | 4.5 |
| Post-therapeutic monitoring | 10 | 2.3 |
| Colposcopy with abnormal Pap smears | 47 | 10.7 |
| Non-specificinflammatorysmear | 27 | 6.1 |
| ASCUS | 8 | 1.8 |
| ASC-H | 5 | 1.1 |
| Low Grade squamous intraepithelial lesions | 4 | 0.9 |
| High Grade squamous intraepithelial lesions | 2 | 0.45 |
| Presence of koilocytes | 1 | 0.2 |
| Total | 440 | 100 |